← Open Payments lookup

MARK RICHMAN: Open Payments

NPI 1124000963 · ADAMSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,798 in 118 payments from 21 companies in 2025. Trend: 2023 $2,471 · 2024 $2,435 · 2025 $2,798

Food & beverage: $2,786Education: $11
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP21$714
Novo Nordisk Inc15$411
Boehringer Ingelheim Pharmaceuticals, Inc.9$228
GlaxoSmithKline, LLC.10$202
Sumitomo Pharma America, Inc.8$195
Bayer Healthcare Pharmaceuticals Inc.9$151
Corcept Therapeutics7$145
Dexcom, Inc.7$129
Paratek Pharmaceuticals, Inc.7$105
Amgen Inc.4$89

Products named: Ozempic, BREZTRI, FARXIGA, JARDIANCE, TRELEGY ELLIPTA, GEMTESA, Kerendia, Korlym.

Industry payments across AL — which companies pay providers there.